Global epigenetic regulation of MicroRNAs in multiple myeloma

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Wenjing ^a,b   Wang, Yaoyu E ^a   Zhang, Yu ^a,c   Leleu, Xavier ^a,d   Reagan, Michaela ^a   Zhang, Yong ^a   Mishima, Yuji ^a   Glavey, Siobhan ^a   Manier, Salomon ^a   Sacco, Antonio ^a   Jiang, Bo ^b   Roccaro, Aldo M ^a   Ghobrial, Irene M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA TUBULIN; BORTEZOMIB; CASPASE 3; CASPASE 9; DNA METHYLTRANSFERASE 1; LENALIDOMIDE; MICRORNA; MICRORNA 10B 5P; MICRORNA 152; MICRORNA 34C 3P; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; AZACITIDINE; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; BTRC PROTEIN, HUMAN; DECITABINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNA BINDING PROTEIN; E2F3 PROTEIN, HUMAN; MESSENGER RNA; MYCBP PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; BTRC GENE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNMT1 GENE; DOWN REGULATION; E2F3 GENE; EPIGENETICS; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MIDDLE AGED; MULTIPLE MYELOMA; MYCBP GENE; MYELOMA CELL; ONCOGENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA METHYLATION; SEQUENCE ALIGNMENT; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; AZACITIDINE; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; E2F3 TRANSCRIPTION FACTOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MULTIPLE MYELOMA; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84908120537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110973     Document Type: Article

References (53)

1. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nature reviews Genetics 3: 415-428.
2. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes & development 16: 6-21.
3. Esteller M (2008) Epigenetics in cancer. The New England journal of medicine 358: 1148-1159.
4. Agirre X, Martinez-Climent JA, Odero MD, Prosper F (2012) Epigenetic regulation of miRNA genes in acute leukemia. Leukemia 26: 395-403.
5. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro E, et al. (2013) MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene.
7. Kureel J, Dixit M, Tyagi AM, Mansoori MN, Srivastava K, et al. (2014) miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell death & disease 5: e1050.
8. Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31: 1609-1622.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
10. Song SJ, Ito K, Ala U, Kats L, Webster K, et al. (2013) The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell stem cell 13: 87-101.
11. Wei J, Wang F, Kong LY, Xu S, Doucette T, et al. (2013) miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer research 73: 3913-3926.
12. Lujambio A, Esteller M (2007) CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell cycle (Georgetown, Tex) 6: 1455-1459.
13. Agnelli L, Bicciato S, Mattioli M, Fabris S, Intini D, et al. (2005) Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23: 7296-7306.
14. Fernandez de Larrea C, Martin-Antonio B, Cibeira MT, Navarro A, Tovar N, et al. (2013) Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib. Leukemia research 37: 641-646.
15. Hatzimichael E, Benetatos L, Dasoula A, Dranitsaris G, Tsiara S, et al. (2009) Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia. Leukemia research 33: 1272-1275.
16. Kaiser MF, Johnson DC, Wu P, Walker BA, Brioli A, et al. (2013) Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood 122: 219-226.
17. Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, et al. (2011) The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 117: 211-220.
18. Scheiermann C, Kunisaki Y, Frenette PS (2013) Circadian control of the immune system. Nature reviews Immunology 13: 190-198.
19. Chim CS, Pang R, Fung TK, Choi CL, Liang R (2007) Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia 21: 2527-2536.
20. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer cell 18: 367-381.
21. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, et al. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer cell 13: 496-506.
22. Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, et al. (2009) MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 113: 6669-6680.
23. Liu Y, Quang P, Braggio E, Ngo H, Badalian-Very G, et al. (2013) Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma. PloS one 8: e66982.
24. Yang J, Chai L, Fowles TC, Alipio Z, Xu D, et al. (2008) Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 105: 19756-19761.
25. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, et al. (2005) Chromosomewide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
26. Toedling J, Huber W (2008) Analyzing ChIP-chip data using bioconductor. PLoS computational biology 4: e1000227.
27. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, et al. (2006) Model-based analysis of tiling-arrays for ChIP-chip. Proceedings of the National Academy of Sciences of the United States of America 103: 12457-12462.
28. Zhang Y, Roccaro AM, Rombaoa C, Flores L, Obad S, et al. (2012) LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas. Blood 120: 1678-1686.
29. Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, et al. (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. The Journal of pathology 229: 12-24.
30. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics (Oxford, England) 18: 1427-1431.
31. Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, et al. (2007) Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 109: 1692-1700.
32. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.
33. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics 34: 267-273.
34. Schadt EE, Li C, Ellis B, Wong WH (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. Journal of cellular biochemistry Supplement Suppl 37: 120-125.
35. Wong KY, Yim RL, So CC, Jin DY, Liang R, et al. (2011) Epigenetic inactivation of the MIR34B/C in multiple myeloma. Blood 118: 5901-5904.
36. Walker BA, Wardell CP, Chiecchio L, Smith EM, Boyd KD, et al. (2011) Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood 117: 553-562.
37. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, et al. (2009) International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 23: 2210-2221.
38. Morgan GJ, Walker BA, Davies FE (2012) The genetic architecture of multiple myeloma. Nature reviews Cancer 12: 335-348.
39. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
40. Yigit MV, Ghosh SK, Kumar M, Petkova V, Kavishwar A, et al. (2013) Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 32: 1530-1538.
41. Ouyang H, Gore J, Deitz S, Korc M (2013) microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene.
42. Kim K, Lee HC, Park JL, Kim M, Kim SY, et al. (2011) Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics: official journal of the DNA Methylation Society 6: 740-751.
43. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, et al. (2010) Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer science 101: 241-249.
44. Xu Q, Jiang Y, Yin Y, Li Q, He J, et al. (2013) A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. Journal of molecular cell biology 5: 3-13.
45. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, et al. (2011) miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer research 71: 6450-6462.
46. Huang J, Wang Y, Guo Y, Sun S (2010) Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology (Baltimore, Md) 52: 60-70.
47. Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, et al. (2011) Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 25: 429-439.
48. Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, et al. (2013) Improved risk stratification in myeloma using a microRNA-based classifier. British journal of haematology 162: 348-359.
49. Rio-Machin A, Ferreira BI, Henry T, Gomez-Lopez G, Agirre X, et al. (2013) Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype. Leukemia 27: 925-931.
50. Hermann A, Gowher H, Jeltsch A (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cellular and molecular life sciences: CMLS 61: 2571-2587.
51. Rady B, Chen Y, Vaca P, Wang Q, Wang Y, et al. (2013) Overexpression of E2F3 promotes proliferation of functional human beta cells without induction of apoptosis. Cell cycle (Georgetown, Tex) 12: 2691-2702.
52. Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, et al. (2001) Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB. The Journal of biological chemistry 276: 27152-27158.
53. Xiong J, Du Q, Liang Z (2010) Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29: 4980-4988.